Actively Recruiting
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Led by Memorial Sloan Kettering Cancer Center · Updated on 2025-10-21
445
Participants Needed
4
Research Sites
249 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Genetic testing is a type of test that detects changes to the genes-the DNA instructions that are passed on from the mother and father. The results of a genetic test can confirm whether the participant has a genetic disorder, which is a disease caused in whole or in part by changes to the genes. Genetic testing can also help determine a person's chance of getting or passing on a genetic disorder. Genetic tests use a sample of blood, hair, skin, or other tissue, and they can look at one gene or multiple genes at the same time. Genetic testing may change the options for treating people with certain types of cancer. For example, some medications are more helpful for the treatment of cancer in people with certain gene changes (mutations). The researchers are doing this study to develop new educational materials about genetic testing for people who speak different languages and have diverse cultural and educational backgrounds. During the study, the staff will interview participants with diverse cultural and educational backgrounds and ask them to review a sample of the educational materials that have been developed so far. Participants will give their opinions on these materials, and the researchers will use participants' feedback to improve the materials.
CONDITIONS
Official Title
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Current or previous diagnosis of breast, ovarian, pancreatic, or prostate cancer (Phase 1) or breast, colorectal, ovarian, pancreatic, or prostate cancer meeting specific criteria (Phase 2)
- Self-identify as Black, Latino, or neither Black nor Latino (Phase 1)
- Fluency in English, Haitian Creole, or Spanish with good spoken and reading ability
- No prior cancer genetic counseling or germline testing for cancer risk (Phase 2)
You will not qualify if you...
- Impaired decision-making capacity as judged by a clinician or consenting professional
- Fluency level of "not at all" or "not well" in required languages
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Kings County Hopsital Center
Brooklyn, New York, United States, 11203
Actively Recruiting
2
Queens Cancer Center of Queens Hospital
Jamaica, New York, United States, 11432
Actively Recruiting
3
Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities)
New York, New York, United States, 10035
Actively Recruiting
4
Jamaica Hospital Medical Center (Data Collection Only)
Richmond Hill, New York, United States, 11418
Actively Recruiting
Research Team
J
Jada Hamilton, PhD, MPH
CONTACT
J
Jennifer Hay, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here